Citations

Atun, R., J. I Davies, E. A M Gale, T. Barnighausen, D. Beran, A. P Kengne, N. S Levitt, F. W Mangugu, M. J Nyirenda, G. D Ogle, K. Ramaiya, N. K Sewankambo, E. Sobngwi, S. Tesfaye, J. S Yudkin, S. Basu, C. Bommer, E. Heesemann, J. Manne-Goehler, I. Postolovska, V. Sagalova, S. Vollmer, Z. G Abbas, B. Ammon, M. T Angamo, A. Annamreddi, A. Awasthi, S. Besancon, S. Bhadriraju, A. Binagwaho, P. I Burgess, M. J Burton, J. Chai, F. P Chilunga, P. Chipendo, A. Conn, D. R Joel, A. W Eagan, C. Gishoma, J. Ho, S. Jong, S. S Kakarmath, Y. Khan, R. Kharel, M. A Kyle, S. C Lee, A. Lichtman, C. P Malm, M. N Mbaye, M. A Muhimpundu, B. M Mwagomba, K. J Mwangi, M. Nair, S. P Niyonsenga, B. Njuguna, O. L O Okafor, O. Okunade, P. H Parker, S. D Pastakia, C. Pekny, A. Reja, C. N Rotimi, S. Rwunganira, D. Sando, G. Sarriera, A. Sharma, A. Sidibe, E. S Siraj, A. A Syed, K. Van Acker, and M. Werfalli. "Diabetes in sub-Saharan Africa: from clinical care to health policy." Lancet Diabetes Endocrinol 5, no. 8 (2017): 622-667.

"Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model." Lancet Glob Health 9, no. 11 (2021): e1539-e1552.

"The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study." Lancet Diabetes Endocrinol 5, no. 6 (2017): 423-430.

"Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030." Diabetes Care 41, no. 5 (2018): 963-970.

"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults." Lancet Healthy Longev 2, no. 6 (2021): e340-e351.

Marcus, M. E, J. Manne-Goehler, M. Theilmann, F. Farzadfar, S. S Moghaddam, M. Keykhaei, A. Hajebi, S. Tschida, J. M Lemp, K. K Aryal, M. Dunn, C. Houehanou, S. Bahendeka, P. Rohloff, R. Atun, T. W Bärnighausen, P. Geldsetzer, and Ramirez. "Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data." The Lancet Global Health 10, no. 3 (2022): e369-e379.

"Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults." JAMA Intern Med 178, no. 3 (2018): 363-372.

"Evaluation of sex differences in dietary behaviours and their relationship with cardiovascular risk factors: a cross-sectional study of nationally representative surveys in seven low- and middle-income countries." Nutr J 19, no. 1 (2020).

"Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition." Lancet 391, no. 10125 (2018): 1108-1120.

"Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys." PLoS Med 18, no. 10 (2021).

"Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data." PLoS Med 18, no. 3 (2021).

"Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries." Diabetes Care 43, no. 4 (2020): 767-775.